Molecular Mechanism of Selective Binding of NMS-P118 to PARP-1 and PARP-2: A Computational Perspective

Ran Wang1, Yalong Cong1, Mengxin Li1

  • 1Shanghai Key Laboratory of Green Chemistry and Chemical Process, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University at Shanghai, Shanghai, China.

Insights

NMS-P118 is a selective poly (ADP-ribose) polymerase-1 (PARP-1) inhibitor. Molecular dynamics simulations reveal key interactions, such as hydrophobic and electrostatic forces, that explain its enhanced binding to PARP-1 over PARP-2.

Area of Science:

  • Biochemistry and Molecular Biology
  • Pharmacology and Drug Discovery

Background:

  • Poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors enhance chemotherapy and radiotherapy efficacy.
  • Current PARP inhibitors often lack selectivity between PARP-1 and PARP-2, limiting their therapeutic potential.

Purpose of the Study:

  • To elucidate the molecular mechanism behind the high selectivity of NMS-P118 for PARP-1 over PARP-2.
  • To identify key amino acid residues and interactions responsible for NMS-P118's selective binding.

Main Methods:

  • Molecular dynamics (MD) simulations of NMS-P118 complexed with PARP-1 and PARP-2.
  • Alanine scanning mutagenesis to probe residue importance.
  • Free energy calculations using MM/GBSA and interaction entropy analysis.

Main Results:

  • Identified specific hot-spot residues in PARP-1 contributing to stronger binding free energy compared to PARP-2.
  • Highlighted favorable hydrophobic interactions between NMS-P118's difluorocyclohexyl ring and Y889 in PARP-1.
  • Revealed stronger hydrogen bonding of H862 in PARP-1 and enhanced electrostatic interactions with E763 in PARP-1.

Conclusions:

  • The study provides a detailed molecular explanation for NMS-P118's selectivity towards PARP-1.
  • Findings can guide the rational design of novel, more selective PARP inhibitors for cancer therapy.